EUVIMED · CrossrefZeitschrift
Exploration of Digestive Diseases
ISSN 2833-6321 · Open Exploration Publishing
Neueste Artikel
Microplastics and microbiota: deciphering the concealed environmental threats to health
How the gut-liver axis shapes hepatic encephalopathy: mechanistic and therapeutic perspectives
Precision prevention of liver cancer based on risk factors
The multiple mechanisms and modes of cell death after acetaminophen overdose
Neurotrophic signaling in liver cancers: mechanisms and potential therapeutic targets
Sex differences in alcohol-related liver disease, viral hepatitis, metabolic dysfunction-associated steatotic liver disease, and hepatocellular carcinoma
Surveillance for cholangiocarcinoma in PSC: MRI, ERCP, both—or neither?
Ixekizumab-associated severe Crohn’s in a patient without definitive immune-mediated inflammatory disease: case report and evidence-informed guidance for non-IBD clinicians
Pediatric cirrhosis: special consideration for its diagnosis and management
The therapeutic potential of bacteriophage therapy in liver cirrhosis: a comprehensive review of current evidence
CRISPR genome editing advances against gastric cancer
Diverticulitis—new evidence to share with patients
GDF11 induces chemosensitization in human hepatocellular carcinoma cells by decreasing drug-efflux transporters
Current efficacy of immune checkpoint inhibitors in microsatellite unstable colorectal cancer and potential biomarkers
Helicobacter pylori infection in the pathophysiology of metabolic dysfunction-associated steatotic liver disease and its complications
Debugging surgical guidelines for acute diverticulitis
Molecular insights into pancreatic cysts: navigating diagnosis and precision management
Fructose induces metabolic reprogramming in liver cancer cells, promoting aggressiveness and chemotherapy resistance
Pharmacotherapy of hepatitis D: the current and the future
Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome
Hepatic fibrosis in morbidly obese patients: fibroscan accuracy
The role of endoscopic ultrasound in esophageal and gastric varices management: a systematic review
Targeting duodenum to reverse MASLD
Considering the fragility index in reporting trials on diverticular disease
Metabolic dysfunction-associated steatotic liver disease (MASLD): emerging insights into gut microbiota interactions and therapeutic perspectives
From cooperation to collapse: systemic failure in liver disease through a sociological lens
DMF, an activator of Nrf2, could mitigate cholic-acid-induced liver damage in high-fat diet
Minimal hepatic encephalopathy: a hidden threat to quality of life in cirrhosis patients
Towards personalized microbial therapies for metabolic alterations in celiac disease
Microbiota and iron metabolism
EUVIMED